This is an action for patent infringement under the patent law of united states, title 35, united states code that arises out of Lupin's submission of ANDA No. 204079 to the FDA seeking approval to manufacturing and selling a generic version of Moxeza ophthalmic solution.
Complaint for Patent Infringement:
Civil Action No. 1:13-cv-01230-UNA; no judge yet assigned.
Filed on July 12, 2013 in the U.S. District Court for the District of Delaware;
Patents in suit:
8,450,311: “Pharmaceutical compositions containing a fluoroquinolone antibiotic drug” by Campins et. al. Prosecuted by Chapple; Scott A.. Includes 17 claims (3 indep.). Was application 12/474,307. Granted 5/28/2013.
Complaint for Patent Infringement:
Civil Action No. 1:13-cv-01230-UNA; no judge yet assigned.
Filed on July 12, 2013 in the U.S. District Court for the District of Delaware;
Patents in suit:
8,450,311: “Pharmaceutical compositions containing a fluoroquinolone antibiotic drug” by Campins et. al. Prosecuted by Chapple; Scott A.. Includes 17 claims (3 indep.). Was application 12/474,307. Granted 5/28/2013.